메뉴 건너뛰기




Volumn 94, Issue SUPPL. 1, 2012, Pages 65-69

Use and interpretation of composite end points in orthopaedic trials

Author keywords

[No Author keywords available]

Indexed keywords

BONE TRANSPLANTATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COMPARTMENT SYNDROME; COMPOSITE END POINT; DEATH; DECISION MAKING; FASCIOTOMY; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; INFECTION; INFECTION RISK; INTRAMEDULLARY NAILING; MORTALITY; ORTHOPEDIC CLINICAL TRIAL; ORTHOPEDICS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RISK FACTOR; RISK REDUCTION; SURGEON; TIBIA FRACTURE; VALIDITY; ARTICLE; BIOASSAY; METHODOLOGY; ORTHOPEDIC SURGERY; REPRODUCIBILITY; RISK; STATISTICAL ANALYSIS; STATISTICS;

EID: 84866914603     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.01287     Document Type: Review
Times cited : (5)

References (28)
  • 1
    • 35448970592 scopus 로고    scopus 로고
    • The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies
    • DOI 10.2106/JBJS.F.01591
    • Chan S, Bhandari M. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. J Bone Joint Surg Am. 2007;89:1970-8. (Pubitemid 350195028)
    • (2007) Journal of Bone and Joint Surgery - Series A , vol.89 , Issue.9 , pp. 1970-1978
    • Chan, S.1    Bhandari, M.2
  • 5
    • 26844517347 scopus 로고    scopus 로고
    • Key issues in end point selection for heart failure trials: Composite end points
    • DOI 10.1016/j.cardfail.2005.08.350, PII S1071916405011802
    • Neaton JD, Gray G, Zuckerman BD, Konstam MA. Key issues in end point selection for heart failure trials: composite end points. J Card Fail. 2005;11:567-75. (Pubitemid 41463726)
    • (2005) Journal of Cardiac Failure , vol.11 , Issue.8 , pp. 567-575
    • Neaton, J.D.1    Gray, G.2    Zuckerman, B.D.3    Konstam, M.A.4
  • 6
    • 0026755718 scopus 로고
    • An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point
    • Braunwald E, Cannon CP, McCabe CH. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. Circulation. 1992;86:683-7.
    • (1992) Circulation , vol.86 , pp. 683-687
    • Braunwald, E.1    Cannon, C.P.2    McCabe, C.H.3
  • 8
    • 0033566652 scopus 로고    scopus 로고
    • Statistical principles for clinical trials (ICH E9): An introductory note on an international guideline
    • Lewis JA. Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline. Stat Med. 1999;18:1903-42.
    • (1999) Stat Med , vol.18 , pp. 1903-1942
    • Lewis, J.A.1
  • 9
    • 0030670029 scopus 로고    scopus 로고
    • Some issues in the construction and use of clusters of outcome events
    • DOI 10.1016/S0197-2456(97)82056-9, PII S0197245697000159
    • Gent M. Discussion: some issues in the construction and use of clusters of outcome events. Control Clin Trials. 1997;18:546-9. (Pubitemid 27520842)
    • (1997) Controlled Clinical Trials , vol.18 , Issue.6 , pp. 546-549
    • Gent, M.1
  • 10
    • 0030670453 scopus 로고    scopus 로고
    • Clinical perspectives on the use of composite endpoints
    • DOI 10.1016/S0197-2456(97)00005-6, PII S0197245697000056
    • Cannon CP. Clinical perspectives on the use of composite endpoints. Control Clin Trials. 1997;18:517-29. (Pubitemid 27520840)
    • (1997) Controlled Clinical Trials , vol.18 , Issue.6 , pp. 517-529
    • Cannon, C.P.1
  • 11
    • 0026549639 scopus 로고
    • A method of assigning scores to the components of a composite outcome: An example from the MITI trial
    • Hallstrom AP, Litwin PE, Weaver WD. A method of assigning scores to the components of a composite outcome: an example from the MITI trial. Control Clin Trials. 1992;13:148-55.
    • (1992) Control Clin Trials , vol.13 , pp. 148-155
    • Hallstrom, A.P.1    Litwin, P.E.2    Weaver, W.D.3
  • 12
    • 0037108042 scopus 로고    scopus 로고
    • Combined endpoints: Can we use them?
    • Lubsen J, Kirwan BA. Combined endpoints: can we use them? Stat Med. 2002; 21:2959-70.
    • (2002) Stat Med , vol.21 , pp. 2959-2970
    • Lubsen, J.1    Kirwan, B.A.2
  • 13
    • 0344307422 scopus 로고    scopus 로고
    • Composite outcomes in clinical trials: Uses and problems
    • Carneiro AV. Composite outcomes in clinical trials: uses and problems. Rev Port Cardiol. 2003;22:1253-63.
    • (2003) Rev Port Cardiol , vol.22 , pp. 1253-1263
    • Carneiro, A.V.1
  • 14
    • 0037636758 scopus 로고    scopus 로고
    • Clinical Trials - Multiple Treatments, Multiple End Points, and Multiple Lessons
    • DOI 10.1001/jama.289.19.2575
    • Lauer MS, Topol EJ. Clinical trials -multiple treatments, multiple end points, and multiple lessons. JAMA. 2003;289:2575-7. (Pubitemid 37430160)
    • (2003) Journal of the American Medical Association , vol.289 , Issue.19 , pp. 2575-2577
    • Lauer, M.S.1    Topol, E.J.2
  • 15
    • 33645227163 scopus 로고    scopus 로고
    • Some issues with composite endpoints in clinical trials
    • DOI 10.1111/j.1472-8206.2005.00370.x
    • Chi GY. Some issues with composite endpoints in clinical trials. Fundam Clin Pharmacol. 2005;19:609-19. (Pubitemid 43821995)
    • (2005) Fundamental and Clinical Pharmacology , vol.19 , Issue.6 , pp. 609-619
    • Chi, G.Y.H.1
  • 16
    • 7944234299 scopus 로고    scopus 로고
    • Language and interpretation of clinical trial outcomes: Alternates, surrogates, and composites
    • DOI 10.1016/j.hrthm.2004.08.005, PII S1547527104004151
    • Myerburg RJ, Castellanos A. Language and interpretation of clinical trial outcomes: alternates, surrogates, and composites. Heart Rhythm. 2004;1:538-9. (Pubitemid 39467710)
    • (2004) Heart Rhythm , vol.1 , Issue.5 , pp. 538-539
    • Myerburg, R.J.1    Castellanos, A.2
  • 17
    • 0034079701 scopus 로고    scopus 로고
    • The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials
    • O'Connor CM, Gattis WA, Ryan TJ. The role of clinical nonfatal end points in cardiovascular phase II/III clinical trials. Am Heart J. 2000;139:S143-54. (Pubitemid 30207809)
    • (2000) American Heart Journal , vol.139 , Issue.4
    • O'Connor, C.M.1    Gattis, W.A.2    Ryan, T.J.3
  • 18
    • 0037072462 scopus 로고    scopus 로고
    • Lessons learned from recent cardiovascular clinical trials: Part I
    • DOI 10.1161/01.CIR.0000023219.51483.66
    • DeMets DL, Califf RM. Lessons learned from recent cardiovascular clinical trials: Part I. Circulation. 2002;106:746-51. (Pubitemid 34851937)
    • (2002) Circulation , vol.106 , Issue.6 , pp. 746-751
    • DeMets, D.L.1    Califf, R.M.2
  • 19
    • 0030723636 scopus 로고    scopus 로고
    • Clinical trials with multiple outcomes: A statistical perspective on their design, analysis, and interpretation
    • DOI 10.1016/S0197-2456(97)00008-1, PII S0197245697000081
    • Pocock SJ. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis, and interpretation. Control Clin Trials. 1997;18:530-45. (Pubitemid 27520841)
    • (1997) Controlled Clinical Trials , vol.18 , Issue.6 , pp. 530-545
    • Pocock, S.J.1
  • 20
    • 2442677734 scopus 로고    scopus 로고
    • The evaluation of the results of clinical trials: Surrogate end points and composite end points
    • Gensini GF, Conti AA. The evaluation of the results of clinical trials: surrogate end points and composite end points. Minerva Med. 2004;95:71-5. (Pubitemid 38667806)
    • (2004) Minerva Medica , vol.95 , Issue.1 , pp. 71-75
    • Gensini, G.F.1    Conti, A.A.2
  • 21
    • 0028931857 scopus 로고
    • Multiple significance tests: The Bonferroni method
    • Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ. 1995;310:170.
    • (1995) BMJ , vol.310 , pp. 170
    • Bland, J.M.1    Altman, D.G.2
  • 22
    • 0025031812 scopus 로고
    • No adjustments are needed for multiple comparisons
    • Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol. 1990;1:43-6. (Pubitemid 20255621)
    • (1990) Epidemiology , vol.1 , Issue.1 , pp. 43-46
    • Rothman, K.J.1
  • 24
    • 38849162727 scopus 로고    scopus 로고
    • In the era of systematic reviews, does the size of an individual trial still matter
    • Guyatt GH, Mills EJ, Elbourne D. In the era of systematic reviews, does the size of an individual trial still matter. PLoS Med. 2008;5:e4.
    • (2008) PLoS Med , vol.5
    • Guyatt, G.H.1    Mills, E.J.2    Elbourne, D.3
  • 26
    • 0034204014 scopus 로고    scopus 로고
    • One thousand health-related quality-of-life estimates
    • Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care. 2000;38:583-637.
    • (2000) Med Care , vol.38 , pp. 583-637
    • Tengs, T.O.1    Wallace, A.2
  • 27
    • 55749083719 scopus 로고    scopus 로고
    • Composite outcomes in cardiovascular research: A survey of randomized trials
    • Lim E, Brown A, Helmy A, Mussa S, Altman DG. Composite outcomes in cardiovascular research: a survey of randomized trials. Ann Intern Med. 2008;149:612-7.
    • (2008) Ann Intern Med , vol.149 , pp. 612-617
    • Lim, E.1    Brown, A.2    Helmy, A.3    Mussa, S.4    Altman, D.G.5
  • 28
    • 57349172170 scopus 로고    scopus 로고
    • Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures
    • Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures Investigators
    • Study to Prospectively Evaluate Reamed Intramedullary Nails in Patients with Tibial Fractures Investigators, Bhandari M, Guyatt G, Tornetta P 3rd, Schemitsch EH, Swiontkowski M, Sanders D, Walter SD. Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am. 2008;90:2567-78.
    • (2008) J Bone Joint Surg Am , vol.90 , pp. 2567-2578
    • Bhandari, M.1    Guyatt, G.2    Tornetta III, P.3    Schemitsch, E.H.4    Swiontkowski, M.5    Sanders, D.6    Walter, S.D.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.